Full Sail Capital »

Regeneron Pharmaceuticals shares owned by Full Sail Capital

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Full Sail Capital from 13F filings

Historical chart of Full Sail Capital investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Full Sail Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Full Sail Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $287k 510 562.27

More positions owned by Full Sail Capital

Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Fidelity Covington Trust Msci Info Tech I (FTEC)
Ishares Core Msci Emkt (IEMG)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Select Sector Spdr Tr Technology (XLK)
American Centy Etf Tr Us Eqt Etf (AVUS)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard World Inf Tech Etf (VGT)
Schwab Strategic Tr Us Tips Etf (SCHP)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Vanguard Intl Equity Index F Ftse Smcap Etf (VSS)
Select Sector Spdr Tr Financial (XLF)

View all positions for Full Sail Capital

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals